Contact Congress about H.R. 3162: Affordable and Safe Prescription Drug Importation Act of 2025
The bill would open new legal paths to buy certain prescription drugs from approved sellers in other countries. Patients could import up to a 90-day supply with a valid U.S. prescription, while businesses would face safety, tracing, and reporting rules.
Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.
Affordable and Safe Prescription Drug Importation Act of 2025 is a House bill in committee. The latest recorded action: Referred to the House Committee on Energy and Commerce.
Latest action on H.R. 3162: Referred to the House Committee on Energy and Commerce.
Who this affects: This bill mainly affects people who use prescription drugs, pharmacies, drug wholesalers, foreign pharmacies, and drug makers. Patients could get a new legal way to buy some medicines from certified foreign pharmacies. Sellers and importers would face new safety, testing, recordkeeping, and reporting rules. Drug makers could face limits on pricing or supply choices that target certified foreign sellers.
Why this matters: This bill matters because high drug prices push some people to look outside the U.S. for medicine, and this bill would create a legal path for some of those purchases. It could increase access to lower-priced drugs, but the savings are not guaranteed. The bill also tries to keep imported drugs safe through certification, tracing, testing, labels, reports, and quick federal action when problems appear.
Key provisions in H.R. 3162
- The Secretary of Health and Human Services must create drug import rules within one year. The rules would cover qualifying prescription drugs from Canada, the United Kingdom, European Union countries, and Switzerland.
- The bill defines which prescription drugs qualify. For importers, it includes insulin, some biologic drugs, peritoneal dialysis solutions, drugs with special safety plans called REMS, and drugs given by IV infusion. It excludes controlled substances, surgical inhaled anesthetics, and compounded drugs made for specific patients.
- Foreign pharmacies and foreign drug wholesalers could become certified foreign sellers. They would need approval from the Secretary, pay a yearly fee, follow safety rules, and be listed on a public federal website.
- People in the U.S. could import up to a 90-day personal supply of qualifying drugs. They must buy from a certified foreign pharmacy, including an online pharmacy, and have a valid prescription from a U.S.-licensed health care provider.
- The Secretary could add more countries later. That could happen only after at least one year of the program and a review of safety data, and only if the country meets drug approval, manufacturing, and safety standards.
How Modern Action helps you take action on H.R. 3162
You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.
Questions people ask about H.R. 3162
- What is H.R. 3162?
- The bill would open new legal paths to buy certain prescription drugs from approved sellers in other countries. Patients could import up to a 90-day supply with a valid U.S. prescription, while businesses would face safety, tracing, and reporting rules.
- How do I support or oppose H.R. 3162?
- Choose support, oppose, or ask for changes on Modern Action. The action flow drafts the message for you and keeps the wording tied to this bill.
- Who should I contact about H.R. 3162?
- Modern Action uses your location to route the action to the congressional offices relevant to the bill and your representation.
- Can Modern Action explain H.R. 3162 before I act?
- Yes. Modern Action gives you a plain-English summary, current status, and action context before you send anything.
